Anchen Sues Labopharm In Bid To Sell Generic Ryzolt
By Erin Coe ( September 30, 2010, 1:25 PM EDT) -- Anchen Pharmaceuticals Inc. has launched a declaratory judgment suit asserting that its plans to market a generic version of pain reliever Ryzolt does not violate a patent held by Canadian drugmaker Labopharm Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.